SAVARA INC (SVRA)

US8051111016 - Common Stock

4.41  -0.04 (-0.9%)

After market: 4.45 +0.04 (+0.91%)

Fundamental Rating

2

SVRA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 588 industry peers in the Biotechnology industry. The financial health of SVRA is average, but there are quite some concerns on its profitability. SVRA is valued expensive and it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

SVRA had negative earnings in the past year.
SVRA had a negative operating cash flow in the past year.
SVRA had negative earnings in each of the past 5 years.
SVRA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SVRA's Return On Assets of -30.81% is fine compared to the rest of the industry. SVRA outperforms 72.01% of its industry peers.
The Return On Equity of SVRA (-38.97%) is better than 75.77% of its industry peers.
Industry RankSector Rank
ROA -30.81%
ROE -38.97%
ROIC N/A
ROA(3y)-27.48%
ROA(5y)-38.13%
ROE(3y)-34.71%
ROE(5y)-51.61%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SVRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

SVRA has more shares outstanding than it did 1 year ago.
SVRA has more shares outstanding than it did 5 years ago.
SVRA has a better debt/assets ratio than last year.

2.2 Solvency

SVRA has an Altman-Z score of 6.66. This indicates that SVRA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SVRA (6.66) is better than 82.94% of its industry peers.
SVRA has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
SVRA has a Debt to Equity ratio of 0.19. This is in the lower half of the industry: SVRA underperforms 67.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 6.66
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

SVRA has a Current Ratio of 15.66. This indicates that SVRA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SVRA (15.66) is better than 91.47% of its industry peers.
A Quick Ratio of 15.66 indicates that SVRA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 15.66, SVRA belongs to the top of the industry, outperforming 91.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.66
Quick Ratio 15.66

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SVRA have decreased strongly by -32.00% in the last year.
EPS 1Y (TTM)-32%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-28.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

Based on estimates for the next years, SVRA will show a very strong growth in Earnings Per Share. The EPS will grow by 32.06% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-19.98%
EPS Next 2Y-3%
EPS Next 3Y14.42%
EPS Next 5Y32.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SVRA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SVRA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SVRA's earnings are expected to grow with 14.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3%
EPS Next 3Y14.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SVRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAVARA INC

NASDAQ:SVRA (4/26/2024, 7:18:14 PM)

After market: 4.45 +0.04 (+0.91%)

4.41

-0.04 (-0.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap609.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.81%
ROE -38.97%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 15.66
Quick Ratio 15.66
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-32%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-19.98%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y